
Benny T. Lee
Examiner (ID: 19283, Phone: (571)272-1764 , Office: P/2842 )
| Most Active Art Unit | 2502 |
| Art Unit(s) | 2506, 2502, 2843, 3621, 2817, 2842 |
| Total Applications | 3420 |
| Issued Applications | 2850 |
| Pending Applications | 182 |
| Abandoned Applications | 416 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6851528
[patent_doc_number] => 20030143731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Use of heterologous transcription factors in gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/002244
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22221
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002244 | Use of heterologous transcription factors in gene therapy | Oct 22, 2001 | Abandoned |
Array
(
[id] => 6242348
[patent_doc_number] => 20020045256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Method for enhancing primordial germ cell number'
[patent_app_type] => new
[patent_app_number] => 09/978877
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7758
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045256.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978877
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978877 | Method for enhancing primordial germ cell number | Oct 15, 2001 | Abandoned |
| 09/889993 | Mammal, method for producing same and its use | Oct 4, 2001 | Abandoned |
Array
(
[id] => 6289152
[patent_doc_number] => 20020054864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Stimulation of cell-mediated immune responses by targeted particulate genetic immunization'
[patent_app_type] => new
[patent_app_number] => 09/967956
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10491
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20020054864.pdf
[firstpage_image] =>[orig_patent_app_number] => 09967956
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/967956 | Stimulation of cell-mediated immune responses by targeted particulate genetic immunization | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6861171
[patent_doc_number] => 20030092179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Animal integration vector and methods for its use'
[patent_app_type] => new
[patent_app_number] => 09/962853
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7232
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092179.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962853
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962853 | Animal integration vector and methods for its use | Sep 23, 2001 | Abandoned |
Array
(
[id] => 1329609
[patent_doc_number] => 06596271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-22
[patent_title] => 'Insect control method with genetically engineered biopesticides'
[patent_app_type] => B2
[patent_app_number] => 09/960760
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7673
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596271.pdf
[firstpage_image] =>[orig_patent_app_number] => 09960760
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/960760 | Insect control method with genetically engineered biopesticides | Sep 20, 2001 | Issued |
Array
(
[id] => 1085580
[patent_doc_number] => 06830925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-14
[patent_title] => 'CaMK-X1 and its uses'
[patent_app_type] => B2
[patent_app_number] => 09/960643
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17628
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/830/06830925.pdf
[firstpage_image] =>[orig_patent_app_number] => 09960643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/960643 | CaMK-X1 and its uses | Sep 19, 2001 | Issued |
Array
(
[id] => 6276674
[patent_doc_number] => 20020106794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Tyrosine hydroxylase 5\' control elements and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/942325
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8412
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106794.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942325
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942325 | Tyrosine hydroxylase 5' control elements and uses thereof | Aug 28, 2001 | Abandoned |
Array
(
[id] => 6779182
[patent_doc_number] => 20030050264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression'
[patent_app_type] => new
[patent_app_number] => 09/932581
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14437
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050264.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932581
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932581 | Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression | Aug 16, 2001 | Issued |
Array
(
[id] => 6935586
[patent_doc_number] => 20010056581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Vectors and methods for the mutagenesis of mammalian genes'
[patent_app_type] => new
[patent_app_number] => 09/931957
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8845
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056581.pdf
[firstpage_image] =>[orig_patent_app_number] => 09931957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/931957 | Vectors and methods for the mutagenesis of mammalian genes | Aug 15, 2001 | Abandoned |
| 09/786052 | Identification of a cdna associated with ischemia in human heart tissue | Aug 13, 2001 | Abandoned |
Array
(
[id] => 6157542
[patent_doc_number] => 20020146711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'MMSC2 - an MMAC1 interacting protein'
[patent_app_type] => new
[patent_app_number] => 09/922101
[patent_app_country] => US
[patent_app_date] => 2001-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27378
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146711.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922101
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922101 | MMSC2 - an MMAC1 interacting protein | Aug 5, 2001 | Abandoned |
Array
(
[id] => 6802504
[patent_doc_number] => 20030097669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5'
[patent_app_type] => new
[patent_app_number] => 09/922584
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6803
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20030097669.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922584
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922584 | Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5 | Aug 2, 2001 | Abandoned |
Array
(
[id] => 5985661
[patent_doc_number] => 20020098473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Novel glutamate transporters'
[patent_app_type] => new
[patent_app_number] => 09/915181
[patent_app_country] => US
[patent_app_date] => 2001-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 34979
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098473.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915181
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915181 | Glutamate transporters | Jul 23, 2001 | Issued |
Array
(
[id] => 5905702
[patent_doc_number] => 20020142315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'DNA marker for cattle growth'
[patent_app_type] => new
[patent_app_number] => 09/910428
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11655
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142315.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910428
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910428 | DNA marker for cattle growth | Jul 18, 2001 | Abandoned |
Array
(
[id] => 1046688
[patent_doc_number] => 06864082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-08
[patent_title] => 'Modified viral surface proteins for binding to extracellular matrix components'
[patent_app_type] => utility
[patent_app_number] => 09/904923
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 10246
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864082.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904923
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904923 | Modified viral surface proteins for binding to extracellular matrix components | Jul 12, 2001 | Issued |
Array
(
[id] => 5987968
[patent_doc_number] => 20020099194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Methods to overexpress a foreign gene in a cell or in an animal in vitro and in vivo'
[patent_app_type] => new
[patent_app_number] => 09/905311
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8777
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905311
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905311 | Methods to overexpress a foreign gene in a cell or in an animal in vitro and in vivo | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6226924
[patent_doc_number] => 20020004938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Models of prion disease'
[patent_app_type] => new
[patent_app_number] => 09/895963
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12649
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004938.pdf
[firstpage_image] =>[orig_patent_app_number] => 09895963
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/895963 | Models of prion disease | Jun 27, 2001 | Issued |
Array
(
[id] => 6033989
[patent_doc_number] => 20020019519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'KIAA0551 polynucleotides and polypeptides use'
[patent_app_type] => new
[patent_app_number] => 09/871916
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11399
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019519.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871916
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871916 | KIAA0551 polynucleotides and polypeptides use | May 31, 2001 | Abandoned |
Array
(
[id] => 7612952
[patent_doc_number] => 06902882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-07
[patent_title] => 'Methods of monitoring production of gene products and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/859155
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25424
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/902/06902882.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859155 | Methods of monitoring production of gene products and uses thereof | May 14, 2001 | Issued |